Stay updated on High-Dose Eteplirsen in DMD Clinical Trial
Sign up to get notified when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.

Latest updates to the High-Dose Eteplirsen in DMD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check45 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check52 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check67 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check74 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check95 days agoChange DetectedThe study on the safety and efficacy of high doses of eteplirsen for Duchenne Muscular Dystrophy has been updated to include a new timeline and additional details on participant eligibility and outcome measures, while previous versions of the study have been removed.SummaryDifference7%
Stay in the know with updates to High-Dose Eteplirsen in DMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.